These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19647276)

  • 1. [Adaptation and validation of the Spanish version of a disease-specific quality of life measure in patients with systemic lupus erythematosus: the Lupus quality of life].
    González-Rodríguez V; Peralta-Ramírez MI; Navarrete-Navarrete N; Callejas-Rubio JL; Santos Ruiz AM; Khamashta M
    Med Clin (Barc); 2010 Jan; 134(1):13-6. PubMed ID: 19647276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
    Conti F; Perricone C; Reboldi G; Gawlicki M; Bartosiewicz I; Pacucci VA; Massaro L; Miranda F; Truglia S; Alessandri C; Spinelli FR; Teh LS; Ceccarelli F; Valesini G
    Lupus; 2014 Jul; 23(8):743-51. PubMed ID: 24569393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients.
    Pamuk ON; Onat AM; Donmez S; Mengüs C; Kisacik B
    Lupus; 2015 Jul; 24(8):816-21. PubMed ID: 25542903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a disease-specific health-related quality of life measure in adult Portuguese patients with systemic lupus erythematosus: LupusQoL-PT.
    Faria R; Alves R; Oliveira DG; Vasconcelos C
    ARP Rheumatol; 2022 Oct; 1(ARP Rheumatology, nº3 2022):210-218. PubMed ID: 35924368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus.
    McElhone K; Abbott J; Shelmerdine J; Bruce IN; Ahmad Y; Gordon C; Peers K; Isenberg D; Ferenkeh-Koroma A; Griffiths B; Akil M; Maddison P; Teh LS
    Arthritis Rheum; 2007 Aug; 57(6):972-9. PubMed ID: 17665467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus.
    Yilmaz-Oner S; Oner C; Dogukan FM; Moses TF; Demir K; Tekayev N; Atagunduz P; Tuglular S; Direskeneli H
    Clin Rheumatol; 2016 Mar; 35(3):617-22. PubMed ID: 25846834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the LupusQoL in Venezuela: A specific measurement of quality of life in patients with systemic lupus erythematosus.
    Carrión-Nessi FS; Marcano-Rojas MV; Freitas-DeNobrega DC; Romero Arocha SR; Antuarez-Magallanes AW; Fuentes-Silva YJ
    Reumatol Clin (Engl Ed); 2022; 18(6):355-360. PubMed ID: 34373232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and the associated factors of the Malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (SLEQoL and LupusQoL).
    Ahmad Pouzi NA; Shaharir SS; Mohd Tamil A; Mustafar R; Ahmad Maulana S; Mageswaren E; Wan Ghazali WS
    PLoS One; 2023; 18(5):e0285461. PubMed ID: 37186611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL(C).
    García-Carrasco M; Mendoza-Pinto C; Cardiel MH; Méndez-Martínez S; García-Villaseñor A; Jiménez-Hernández C; Alonso-García NE; Briones-Rojas R; Ramos-Álvarez G; López-Colombo A
    Lupus; 2012 Oct; 21(11):1219-24. PubMed ID: 22875651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
    Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
    J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE.
    Devilliers H; Amoura Z; Besancenot JF; Bonnotte B; Pasquali JL; Wahl D; Maurier F; Kaminsky P; Pennaforte JL; Magy-Bertrand N; Arnaud L; Binquet C; Guillemin F; Bonithon-Kopp C
    Rheumatology (Oxford); 2015 May; 54(5):940-9. PubMed ID: 25361539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of an Argentine version of Lupus Quality of Life questionnaire.
    Machado Escobar MA; Yacuzzi MS; Martinez RN; González Lucero L; Bellomio VI; Santana M; Galindo L; Mayer MM; Barreira JC; Sarano J; Gomez G; Collado MV; Martinez A; Orozco MC; Betancur G; Dal Pra F; Sanchez A; Juarez V; Lucero EV
    Lupus; 2016 Dec; 25(14):1615-1622. PubMed ID: 27444335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus-specific health outcome measure for US patients: the LupusQoL-US version.
    Jolly M; Pickard AS; Wilke C; Mikolaitis RA; Teh LS; McElhone K; Fogg L; Block J
    Ann Rheum Dis; 2010 Jan; 69(1):29-33. PubMed ID: 19126561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LupusQoL-FR is valid to assess quality of life in patients with systemic lupus erythematosus.
    Devilliers H; Amoura Z; Besancenot JF; Bonnotte B; Pasquali JL; Wahl D; Maurier F; Kaminsky P; Pennaforte JL; Magy-Bertrand N; Arnaud L; Binquet C; Guillemin F
    Rheumatology (Oxford); 2012 Oct; 51(10):1906-15. PubMed ID: 22826305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus.
    Nantes SG; Strand V; Su J; Touma Z
    Arthritis Care Res (Hoboken); 2018 Jan; 70(1):125-133. PubMed ID: 28320078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of LupusQoL-China for the assessment of health related quality of life in Chinese patients with systemic lupus erythematosus.
    Wang SL; Wu B; Leng L; Bucala R; Lu LJ
    PLoS One; 2013; 8(5):e63795. PubMed ID: 23717486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus.
    McElhone K; Castelino M; Abbott J; Bruce IN; Ahmad Y; Shelmerdine J; Peers K; Isenberg D; Ferenkeh-Koroma A; Griffiths B; Akil M; Maddison P; Gordon C; Teh LS
    J Rheumatol; 2010 Nov; 37(11):2273-9. PubMed ID: 20810500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?
    Touma Z; Gladman DD; Ibañez D; Urowitz MB
    J Rheumatol; 2011 Sep; 38(9):1898-905. PubMed ID: 21724700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the LupusQoL in Venezuela: A Specific Measurement of Quality of Life in Patients with Systemic Lupus Erythematosus.
    Carrión-Nessi FS; Marcano-Rojas MV; Freitas-DeNobrega DC; Romero Arocha SR; Antuarez-Magallanes AW; Fuentes-Silva YJ
    Reumatol Clin (Engl Ed); 2021 Apr; ():. PubMed ID: 33931336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol.
    Etchegaray-Morales I; Méndez-Martínez S; Jiménez-Hernández C; Mendoza-Pinto C; Alonso-García NE; Montiel-Jarquín A; López-Colombo A; García-Villaseñor A; Cardiel MH; García-Carrasco M
    PLoS One; 2017; 12(1):e0170209. PubMed ID: 28114336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.